A novel nonsense variant in the ATL3 gene is associated with disturbed pain sensitivity, numbness of distal limbs and muscle weakness.


Journal

Annals of human genetics
ISSN: 1469-1809
Titre abrégé: Ann Hum Genet
Pays: England
ID NLM: 0416661

Informations de publication

Date de publication:
07 2023
Historique:
revised: 09 01 2023
received: 06 07 2022
accepted: 27 01 2023
medline: 21 6 2023
pubmed: 2 3 2023
entrez: 1 3 2023
Statut: ppublish

Résumé

Introduction Hereditary sensory neuropathy (HSN) describes as a heterogeneous group of peripheral neuropathies. HSN type 1 (HSN1) is one subtype characterized by distal sensory impairment that occurs in the form of numbness, tingling, or pain. To date, only two variants in the atlastin GTPase 3 (ATL3) gene have been identified that result in hereditary sensory neuropathy type 1F (HSN1F) with autosomal dominantinheritance. Methods We sudied and examined who present with sensory disturbances and muscle weakness in their lower limb. Patients underwent Whole Exome Sequencing and Sanger sequencing was performed in families for validation of detected variant. Results Here, we identified two Iranian families carrying the novel heterozygous stop variant NM_015459.5: c.16C>T, p.Arg6Ter in ATL3 that led to disturbed pain and touch sensitivity. This variant in the ATL3 gene was detected in both families (NM_015459.5: c.16C>T, p.Arg6Ter) by whole-exome sequencing and confirmed by Sanger sequencing. Conclusion In this study, the subjects manifested weakness of distal limb muscles and numbness of the lower extremities. In addition, some unusual features, including hearing problems and inability to sit and walk presented in one of the patients. Eventually, we provide a case-based review of the clinical features associated with HSN1F. Hitherto, only 11 patients with HSN1F have been reported. We compared our findings to previously reported cases, suggesting that the clinical features are generally variable in the HSN1F patients.

Identifiants

pubmed: 36856139
doi: 10.1111/ahg.12501
doi:

Substances chimiques

ATL3 protein, human EC 3.6.5.-
GTP Phosphohydrolases EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-157

Informations de copyright

© 2023 John Wiley & Sons Ltd/University College London.

Références

Aboul-Soud, M. A., Alzahrani, A. J., & Mahmoud, A. (2021). Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing. Saudi Journal of Biological Sciences, 28(1), 628-634.
Auer-Grumbach, M. (2008). Hereditary sensory neuropathy type I. Orphanet Journal of Rare Diseases, 3, 7. https://doi.org/10.1186/1750-1172-3-7
Auer-Grumbach, M. (2013). Hereditary sensory and autonomic neuropathies. Handbook of Clinical Neurology, 115, 893-906. https://doi.org/10.1016/b978-0-444-52902-2.00050-3
Behrendt, L., Kurth, I., & Kaether, C. (2019). A disease causing ATLASTIN 3 mutation affects multiple endoplasmic reticulum-related pathways. Cellular and Molecular Life Sciences, 76(7), 1433-1445. https://doi.org/10.1007/s00018-019-03010-x
Chen, Q., Teng, J., & Chen, J. (2019). ATL3, a cargo receptor for reticulophagy. Autophagy, 15(8), 1465-1466. https://doi.org/10.1080/15548627.2019.1609862
Chen, Y. C., Auer-Grumbach, M., Matsukawa, S., Zitzelsberger, M., Themistocleous, A. C., Strom, T. M., & Senderek, J. (2015). Transcriptional regulator PRDM12 is essential for human pain perception. Nature Genetics, 47(7), 803-808. https://doi.org/10.1038/ng.3308
Fagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., & Uhlén, M. (2014). Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & Cellular Proteomics, 13(2), 397-406. https://doi.org/10.1074/mcp.M113.035600
Fattahi, Z., Beheshtian, M., Mohseni, M., Poustchi, H., Sellars, E., Nezhadi, S. H., & Jamali, P. (2019). Iranome: A catalog of genomic variations in the Iranian population. Human Mutation, 40(11), 1968-1984.
Fischer, D., Schabhüttl, M., Wieland, T., Windhager, R., Strom, T. M., & Auer-Grumbach, M. (2014). A novel missense mutation confirms ATL3 as a gene for hereditary sensory neuropathy type 1. Brain, 137(Pt 7), e286. https://doi.org/10.1093/brain/awu091
Howe, K. L., Achuthan, P., Allen, J., Allen, J., Alvarez-Jarreta, J., Amode, M. R., & Flicek, P. (2020). Ensembl 2021. Nucleic Acids Research, 49(D1), D884-D891. https://doi.org/10.1093/nar/gkaa942
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., & Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583-589. https://doi.org/10.1038/s41586-021-03819-2
Kopanos, C., Tsiolkas, V., Kouris, A., Chapple, C. E., Albarca Aguilera, M., Meyer, R., & Massouras, A. (2019). VarSome: The human genomic variant search engine. Bioinformatics, 35(11), 1978-1980. https://doi.org/10.1093/bioinformatics/bty897
Kornak, U., Mademan, I., Schinke, M., Voigt, M., Krawitz, P., Hecht, J., & Kurth, I. (2014). Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain, 137(Pt 3), 683-692. https://doi.org/10.1093/brain/awt357
Krols, M., Asselbergh, B., De Rycke, R., De Winter, V., Seyer, A., Müller, F. J., & Janssens, S. (2019). Sensory neuropathy-causing mutations in ATL3 affect ER-mitochondria contact sites and impair axonal mitochondrial distribution. Human Molecular Genetics, 28(4), 615-627. https://doi.org/10.1093/hmg/ddy352
Krols, M., Detry, S., Asselbergh, B., Almeida-Souza, L., Kremer, A., Lippens, S., & Janssens, S. (2018). Sensory-Neuropathy-Causing Mutations in ATL3 Cause Aberrant ER Membrane Tethering. Cell reports, 23(7), 2026-2038. https://doi.org/10.1016/j.celrep.2018.04.071
Leipold, E., Liebmann, L., Korenke, G. C., Heinrich, T., Giesselmann, S., Baets, J., & Kurth, I. (2013). A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nature Genetics, 45(11), 1399-1404. https://doi.org/10.1038/ng.2767
Li, H., & Durbin, R. (2010). Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 26(5), 589-595. https://doi.org/10.1093/bioinformatics/btp698
O'Donnell, J. P., Cooley, R. B., Kelly, C. M., Miller, K., Andersen, O. S., Rusinova, R., & Sondermann, H. (2017). Timing and reset mechanism of GTP hydrolysis-driven conformational changes of Atlastin. Structure (London, England), 25(7), 997-1010.e1014. https://doi.org/10.1016/j.str.2017.05.007
Ren, J., Wen, L., Gao, X., Jin, C., Xue, Y., & Yao, X. (2009). DOG 1.0: Illustrator of protein domain structures. Cell Research, 19(2), 271-273. https://doi.org/10.1038/cr.2009.6
Rotthier, A., Baets, J., Timmerman, V., & Janssens, K. (2012). Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nature Reviews Neurology, 8(2), 73-85. https://doi.org/10.1038/nrneurol.2011.227
Rychlik, W. (2007). OLIGO 7 primer analysis software. Methods in Molecular Biology, 402, 35-60. https://doi.org/10.1007/978-1-59745-528-2_2
The UniProt Consortium. (2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Research, 49(D1), D480-D489. https://doi.org/10.1093/nar/gkaa1100
Wang, K., Li, M., & Hakonarson, H. (2010). ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research, 38(16), e164. https://doi.org/10.1093/nar/gkq603
Xu, H., Zhang, C., Cao, L., Song, J., Xu, X., Zhang, B., & Zhao, G. (2019). ATL3 gene mutation in a Chinese family with hereditary sensory neuropathy type 1F. Journal of the Peripheral Nervous System, 24(1), 150-155. https://doi.org/10.1111/jns.12309
Zeraatpisheh, Z., Sichani, A. S., Kamal, N., Khamirani, H. J., Zoghi, S., Ehsani, E., & Tabei, S. M. B. (2022). MCM2 mutation causes autosomal dominant nonsyndromic hearing loss (DFNA70): Novel variant in the second family. Journal of Genetics, 101(1), 1-6.
Zhao, G., Zhu, P. P., Renvoisé, B., Maldonado-Báez, L., Park, S. H., & Blackstone, C. (2016). Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology. Experimental Cell Research, 349(1), 32-44. https://doi.org/10.1016/j.yexcr.2016.09.015

Auteurs

Sanaz Mohammadi (S)

Comprehensive Medical Genetic Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Hossein Jafari Khamirani (H)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Baneshi (M)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Neda Kamal (N)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Jamal Manoocheri (J)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Mahsa Saffar (M)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehdi Dianatpour (M)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Seyed Mohammad Bagher Tabei (SMB)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Maternal-fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Seyed Alireza Dastgheib (SA)

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH